R386-702-6. Mandatory Submission of Clinical Material

(1) Each laboratory shall submit clinical material from each case identified with any organism listed in Section R386-702-4 to UPHL within three working days of identification. (2)(a) Submission of clinical material is mandatory for: (i) any antibiotic-resistant organism, from any specimen, that: (A) is resistant to vancomycin in Staphylococcus aureus (VRSA); (B) is resistant to a carbapenem in: (I) Acinetobacter species; (II) any Enterobacterales organism; (III) Pseudomonas aeruginosa that is not susceptible to: (Aa) ceftolozane/tazobactam; or (Bb) cefepime or ceftazidime when ceftolozane/tazobactam resistance is unknown; (C) demonstrates carbapenemase production in: (I) Acinetobacter species; (II) any Enterobacterales organism; or (III) Pseudomonas aeruginosa; (ii) Campylobacter species; (iii) Candida auris or Candida haemulonii from any body site; (iv) Corynebacterium diphtheriae; (v) Cronobacter sakazakii, from a normally sterile site in a person less than 12 months old; (vi) Shiga toxin-producing Escherichia coli including enrichment or MacConkey broths that tested positive by any method for Shiga toxin; (vii) Haemophilus influenzae from a normally sterile site; (viii) influenza A virus, unsubtypeable; (ix) influenza virus in a hospitalized case; (x) Legionella species; (xi) Listeria monocytogenes; (xii) measles (rubeola); (xiii) Mycobacterium tuberculosis complex; (xiv) Neisseria meningitidis, from a normally sterile site; (xv) Salmonella species; (xvi) any SARS-CoV-2 NAAT-positive sample; (xvii) Shigella species; (xviii) Vibrio species; (xix) West Nile virus; (xx) Yersinia species; (xxi) Zika disease; (xxii) any organism implicated in an outbreak when instructed by authorized local or state health department personnel; or (xxiii) any potential bioterrorism agent, including: (A) Bacillus anthracis; (B) Brucella species; (C) Clostridium botulinum; (D) Francisella tularensis; and (E) Yersinia pestis. (b) The department may suspend or modify mandatory submission requirements. (3) If a laboratory identifies a case with an organism designated by UPHL as a potential bioterrorism agent, the laboratory shall immediately notify UPHL by phone before submitting clinical material from the case. (a) During business hours, the phone number for UPHL is 801-965-2400. (b) After hours, the phone number for UPHL is 801-560-6586. (4) Submission of clinical material does not replace the requirement for laboratories to report the event to the department as specified in Sections R386-702-7 and R386-702-8. (5) For additional information on the process described in this section, contact UPHL at 801-965-2400.